AAAAAA

   
Results: 1-18 |
Results: 18

Authors: Mertens, K
Citation: K. Mertens, The future of plasma derivatives, TRANSF CL B, 8(3), 2001, pp. 303-305

Authors: Gao, CQ Giri, M Van Hoecke, MJ Mertens, K Van Den Saffele, J Kaufman, JM
Citation: Cq. Gao et al., Marked species specificity of guinea pig luteinizing hormone: Validation of a bioassay, J ANDROLOGY, 22(2), 2001, pp. 226-234

Authors: Christophe, OD Lenting, PJ Cherel, G Boon-Spijker, M Lavergne, JM Boertjes, R Briquel, ME de Goede-Bolder, A Goudemand, J Gaillard, S d'Oiron, R Meyer, D Mertens, K
Citation: Od. Christophe et al., Functional mapping of anti-factor IX inhibitors developed in patients withsevere hemophilia B, BLOOD, 98(5), 2001, pp. 1416-1423

Authors: van den Brink, EN Turenhout, EAM Bovenschen, N Heijnen, BGADH Mertens, K Peters, M Voorberg, J
Citation: En. Van Den Brink et al., Multiple VH genes are used to assemble human antibodies directed toward the A3-Cl domains of factor VIII, BLOOD, 97(4), 2001, pp. 966-972

Authors: Kolkman, JA Mertens, K
Citation: Ja. Kolkman et K. Mertens, Surface-loop residue Lys(316) in blood coagulation Factor IX is a major determinant for Factor X but not antithrombin recognition, BIOCHEM J, 350, 2000, pp. 701-707

Authors: Mertens, K
Citation: K. Mertens, Husserl's phenomenology of the monads. Remarks on Husserl's confrontation with Leibniz, HUSSERL ST, 17(1), 2000, pp. 1-20

Authors: Celie, PHN Lenting, PJ Mertens, K
Citation: Phn. Celie et al., Hydrophobic contact between the two epidermal growth factor-like domains of blood coagulation factor IX contributes to enzymatic activity, J BIOL CHEM, 275(1), 2000, pp. 229-234

Authors: Neels, JG van den Berg, BMM Mertens, K ter Maat, H Pannekoek, H van Zonneveld, AJ Lenting, PJ
Citation: Jg. Neels et al., Activation of factor IX zymogen results in exposure of a binding site for low-density lipoprotein receptor-related protein, BLOOD, 96(10), 2000, pp. 3459-3465

Authors: Kolkman, JA Mertens, K
Citation: Ja. Kolkman et K. Mertens, Insertion loop 256-268 in coagulation factor IX restricts enzymatic activity in the absence but not in the presence of factor VIII, BIOCHEM, 39(25), 2000, pp. 7398-7405

Authors: Van Herreweghe, I Mertens, K Maes, V Ramet, J
Citation: I. Van Herreweghe et al., Orphenadrine poisoning in a child: clinical and analytical data, INTEN CAR M, 25(10), 1999, pp. 1134-1136

Authors: Mertens, K Celie, PHN Kolkman, JA Lenting, PJ
Citation: K. Mertens et al., Factor VIII-factor IX interactions: Molecular sites involved in enzyme-cofactor complex assembly, THROMB HAEM, 82(2), 1999, pp. 209-217

Authors: White, GC DiMichele, D Mertens, K Negrier, C Peake, IR Prowse, C Schwaab, R Yoshioka, A Ingerslev, J
Citation: Gc. White et al., Utilization of previously treated patients (PTPs), noninfected patients (NIPs), and previously untreated patients (PUPs) in the evaluation of new factor VIII and factor IX concentrates - Recommendation of the Scientific Subcommittee on Factor VIII and Factor IX of the Scientific and StandardizationCommittee of the International Society on Thrombosis and Haemostasis, THROMB HAEM, 81(3), 1999, pp. 462-462

Authors: Kolkman, JA Lenting, PJ Mertens, K
Citation: Ja. Kolkman et al., Regions 301-303 and 333-339 in the catalytic domain of blood coagulation Factor IX are Factor VIII-interactive sites involved in stimulation of enzyme activity, BIOCHEM J, 339, 1999, pp. 217-221

Authors: Szuwart, T Zhao, B Fritsch, A Mertens, K Dierichs, R
Citation: T. Szuwart et al., Oxidized low-density lipoprotein inhibits the binding of monoclonal antibody to platelet glycoprotein IIb-IIIa, THROMB RES, 96(2), 1999, pp. 85-90

Authors: Kolkman, JA Christophe, OD Lenting, PJ Mertens, K
Citation: Ja. Kolkman et al., Surface loop 199-204 in blood coagulation factor IX is a cofactor-dependent site involved in macromolecular substrate interaction, J BIOL CHEM, 274(41), 1999, pp. 29087-29093

Authors: Lenting, PJ Neels, JG van den Berg, BMM Clijsters, PPFM Meijerman, DWE Pannekoek, H van Mourik, JA Mertens, K van Zonneveld, AJ
Citation: Pj. Lenting et al., The light chain of factor VIII comprises a binding site for low density lipoprotein receptor-related protein, J BIOL CHEM, 274(34), 1999, pp. 23734-23739

Authors: Celie, PHN van Stempvoort, G Jorieux, S Mazurier, C van Mourik, JA Mertens, K
Citation: Phn. Celie et al., Substitution of Arg(527) and Arg(531) in factor VIII associated with mild haemophilia A: characterization in terms of subunit interaction and cofactor function, BR J HAEM, 106(3), 1999, pp. 792-800

Authors: Mertens, K
Citation: K. Mertens, Transcendental experience. Preliminary studies towards a transcendental methodology, HUSSERL ST, 15(3), 1998, pp. 231-238
Risultati: 1-18 |